statistiche ricercatore

Continente	#
NA - Nord America	781
EU - Europa	612
AS - Asia	323
SA - Sud America	97
Continente sconosciuto - Info sul continente non disponibili	40
AF - Africa	15
Totale	1.868

Nazione	#
US - Stati Uniti d'America	741
RU - Federazione Russa	332
SG - Singapore	111
BR - Brasile	83
CN - Cina	66
SE - Svezia	60
IT - Italia	57
IE - Irlanda	55
HK - Hong Kong	37
BD - Bangladesh	27
FR - Francia	24
GB - Regno Unito	18
VN - Vietnam	18
AT - Austria	16
CA - Canada	12
FI - Finlandia	12
DE - Germania	11
MX - Messico	10
TR - Turchia	10
NL - Olanda	9
ID - Indonesia	8
HN - Honduras	7
IN - India	7
JP - Giappone	7
IL - Israele	5
AR - Argentina	4
IQ - Iraq	4
AZ - Azerbaigian	3
CO - Colombia	3
EE - Estonia	3
KR - Corea	3
PL - Polonia	3
ZA - Sudafrica	3
BG - Bulgaria	2
CH - Svizzera	2
KH - Cambogia	2
KZ - Kazakistan	2
LU - Lussemburgo	2
MA - Marocco	2
PE - Perù	2
PH - Filippine	2
PK - Pakistan	2
PR - Porto Rico	2
SA - Arabia Saudita	2
SC - Seychelles	2
SV - El Salvador	2
TH - Thailandia	2
TN - Tunisia	2
TW - Taiwan	2
UY - Uruguay	2
AE - Emirati Arabi Uniti	1
BB - Barbados	1
BW - Botswana	1
BY - Bielorussia	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
ES - Italia	1
EU - Europa	1
GP - Guadalupe	1
GT - Guatemala	1
GY - Guiana	1
KE - Kenya	1
LT - Lituania	1
LV - Lettonia	1
MG - Madagascar	1
MU - Mauritius	1
MY - Malesia	1
PA - Panama	1
PY - Paraguay	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
VE - Venezuela	1
VI - Stati Uniti Isole Vergini	1
Totale	1.830

Nome	#
Functional inactivation of E-cadherin by Trop-2 drives cancer metastasis	325
Phylogenetic conservation of Trop-2 across species—rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks	204
Genomic risk for cancer activation profiles of Trop-1 and Trop-2	196
Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis	181
Abstract 2851: Trop-2 inactivates E-cadherin for metastatic diffusion in the absence of EMT	158
Abstract PD15-04: Trop-2 inactivation of E-cadherin drives triple negative breast cancer relapse	156
3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability	152
E-cadherin inactivation by Trop-2 drives EMT-less metastatic relapse in triple-negative breast cancer	136
Functional inactivation of E-cadherin drives EMT-less metastasis	134
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer	106
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody	83
null	37
Totale	1.868

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	59	0	0	0	0	3	3	3	2	1	7	12	28
2022/2023	173	14	27	7	8	10	20	6	13	58	0	8	2
2023/2024	84	3	3	12	6	6	12	7	24	0	6	1	4
2024/2025	313	8	8	0	19	24	30	32	40	70	18	32	32
2025/2026	1.013	60	85	145	90	94	190	70	102	94	33	16	34
2026/2027	190	25	28	46	81	10	0	0	0	0	0	0	0
Totale													1.868